Radiotherapie Hirslanden
Latest medical technologies
Advanced treatment centres
Private medical centres
Radiotherapie Hirslanden AG operates over two sites, at Klinik Hirslanden in Zurich and in nearby Aarau and is one of only a few radiotherapy institutes in Europe to offer the full range of treatments.
CyberKnife® radiosurgery treats small, well-defined, early stage tumours with uprecedented power and accuracy, even when located in inaccessible areas which make them inoperable to a surgeon.
Trilogy® radiotherapy uses a broader beam than CyberKnife so does not achieve the same high precision, but it can treat a wider range of conditions.
The width of the radiation beam can be adapted to the volume of the tumour and it also has stereotactic abilities in some body areas. This enables it to fix the location of the tumour before and during each treatment session.
The tumour can therefore be targeted more accurately than with conventional radiotherapy. Not only does this reduce damage to surrounding healthy tissue, but it enables greater power to be used, which shortens each treatment session.
Some patients face long delays in obtaining radiotherapy in their own countries, but Radiotherapie Hirslanden has three Trilogy radiotherapy systems. Treatment can usually be commenced as soon as international patients can arrange to attend.
Intrabeam® intraoperative 'photon' radiotherapy applies radiotherapy internally during a lumpectomy, directly to the tumour bed. This saves weeks of external radiotherapy later and resulting radiation burn to sensitive skin.
Internal radiotherapy saves radiation burn to sensitive skin
Klinik Hirslanden is one of a small but growing number of centres around the world which use this system. Patients must enrol in a clinical trial and Intrabeam will not be suitable for all cases (we understand approx 50%) but several patients each month do receive treatment in Zurich.
Brachytherapy
In brachytherapy, the radiation source is placed in direct contact with the tumour. The advantage is that the radiation takes effect directly in the malignant tissue. This means that the fall-off of in the radiation dose in the surrounding tissue is much higher than with external radiotherapy.
Brachytherapy therefore allows a higher radiation dose to be administered in the shortest possible time. The total duration of treatment is, in general, reduced from six weeks to one week. A further advantage is the significantly lower radiation exposure of patients compared to traditional radiotherapy.
The Radiotherapie Hirslanden team
Dr Christian von Briel
Radio-oncology
Radio-oncology
Dr Günther Gruber
Radio-oncology
Radio-oncology
Dr Jürgen Curschmann
Radio-oncology
Radio-oncology
Radiotherapie Hirslanden team - click picture to enlarge
Your case will automatically be reviewed by a multidisciplinary panel to sensure that the most appropriate therapy or combination of therapies is applied.
Zurich and Aarau, Switzerland
Visit the CyberKnife page for further details
It can also target complex shapes and some treatments can be completed in a single, painless session. Most other treatments can be provided within three 90-minute sessions on consecutive days.
Visit the manufacturer's web site for more information on Trilogy® radiotherapy.
Trilogy stereotactic radiotherapy
No waiting for radiotherapy
Cases can only be assessed during the operation. Those not suited to this treatment proceed to external radiotherapy in the normal way.
Even with advanced tumours or the recurrence of a tumour following radiotherapy, brachytherapy offers patients considerable advantages. It may be used alone or in conjunction with traditional radiotherapy and/or chemotherapy.
Treatment enquiries
Please complete the Hirslanden enquiry form or you can send an e-mail to:
Please visit our dedicated CyberKnife web site and complete the CyberKnife enquiry form. This allows you to select up to three centres to review your case.
CyberKnife only
All other enquiries
Specialist treatments < CyberKnife radiosurgery < CyberKnife centres < Radiotherapie Hirslanden
Radiotherapie Hirslanden works with Oncology, Urology and other specialities within Klinik Hirslanden so you do not have to specify which form of treatment you are seeking.
MHL international web sites
MHLclinics.com
Web sites in 30 countries
Click map for details
© 2006-2012 Medilux Healthcare Ltd
All rights reserved
All rights reserved
MHL (Medilux Healthcare Ltd.) promotes individual hospitals or hospital groups which we believe offer high standards of care. We provide you with general information and details of how to make contact with the centre, but we shall not be responsible for the quality of any diagnosis or treatment given or for the failure to diagnose or treat any condition. We cannot advise or enter into correspondence about individual cases and we do not arrange or facilitate treatments.
Important note to all patients